Categories: Launch

His Excellency Sheikh Nahyan bin Mubarak, Minister of Tolerance, inaugurates CPhI Middle East & Africa 2019

Pharmaceutical professionals from across the world descend upon ADNEC in Abu Dhabi for the region’s leading platform for the pharma market 

Abu Dhabi, September 18, 2019: His Excellency Sheikh Nahyan, Minister of Tolerance, today officially inaugurated CPhI Middle East & Africa 2019, the region’s leading platform for the pharmaceutical industry followed by a tour of the exhibition and introducing the keynote session.

The event, which is returning for a second year after its successful launch in the capital last year and sponsored by the Ministry of Health and Protection (MoHaP), will take place at the Abu Dhabi National Exhibition Centre (ADNEC) from 16-18 September 2019. The event is providing a showcase for over 294 exhibitors and is expecting to attract 4,900+ visitors.

The onsite conference programme opened with a keynote speech from His Excellency Dr Amin Hussain Al Amiri, Assistant Undersecretary of Public Health Policy & Licensing Sector in UAE Ministry of Health & Prevention, MoHaP. Entitled Healthcare and Pharmaceutical Continuum: Highlights Across the Region, where he addressed a number of topics including a focus on Middle East healthcare systems, creating value for patients and society, R&D investments and an overview on creating a smart regulatory environment for the UAE.

According to research commissioned by CPhI, the pharma market in the MENA region is set to top US$41 billion by 2022 while also increasing partnership and business opportunities at both a local and international and to further increase the value of the market in this region.

A total of 14 sessions are scheduled for the three-day showcase, including on day one An Industry Players Perspective on Pharma Manufacturing in the GCC, The Forgotten

CPhI MEA takes place from 16-18 September, for further information please visit www.cphi.com/mea.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

8 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago